INS and type 2 diabetes mellitus: The Opt2mise Glucose Control in Type 2 Diabetes Mellitus With Insulin Pump Therapy (OpT2mise) was the first large scale randomized trial that studied the effects of insulin pump therapy in 331 adults with T2D, including 69 subjects aged 65 years and older.